Verdence Capital Advisors LLC grew its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 4.3% in the 3rd quarter, ...

"Tivic hits enrolment target for vagus nerve stimulation trial" was originally created and published by Medical Device ...

If you’re on the fence about investing in Boston Scientific Corporation or Thermo ... artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological ...

It is a population that’s not indicated for ablation today under guidelines, and it’s not the population that’s being treated today with the Farapulse system,” explained Stein in the Q3 earnings call.

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

TMOThermo Fisher Scientific Inc.

Read all the stories you want.